Autoren

David Mulder

Counsel

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partnerin

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More
Autoren

David Mulder

Counsel

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partnerin

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More

9. November 2020

Pharmaceutical patent law – 1 von 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

In dieser Serie

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9. November 2020

von mehreren Autoren

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23. November 2020

von mehreren Autoren

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Life Sciences & Healthcare

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22. März 2024
Briefing

von Dr. Anja Lunze, LL.M. und Tobias Baus, LL.M., Dipl.-Ing.

Klicken Sie hier für Details
UPC

The first 100 days of the UPC from a life sciences perspective – a very good message

20. September 2023
Quick read

von Dr. Anja Lunze, LL.M. und Dr. Nora E. Wessendorf, LL.M. (Washington)

Klicken Sie hier für Details
Life Sciences & Healthcare

Personalised medicines and exclusive protection

19. Juli 2023

von Dr Paul England

Klicken Sie hier für Details